Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 4—April 2018
Research

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015

Sandra N. BulensComments to Author , Sarah H. Yi, Maroya S. Walters, Jesse T. Jacob, Chris Bower, Jessica Reno, Lucy Wilson, Elisabeth Vaeth, Wendy Bamberg, Sarah J. Janelle, Ruth Lynfield, Paula Snippes Vagnone, Kristin Shaw, Marion Kainer, Daniel Muleta, Jacqueline Mounsey, Ghinwa Dumyati, Cathleen Concannon, Zintars Beldavs, P. Maureen Cassidy, Erin C. Phipps, Nicole Kenslow, Emily B. Hancock, and Alexander J. Kallen
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.N. Bulens, S.H. Yi, M.S. Walters, A.J. Kallen); Emory University School of Medicine, Atlanta (J.T. Jacob); Georgia Emerging Infections Program, Atlanta (J.T. Jacob, C. Bower, J. Reno); Atlanta Veterans Affairs Medical Center, Decatur, Georgia, USA (C. Bower, J. Reno); Atlanta Research and Education Foundation, Decatur (C. Bower, J. Reno); Maryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA (L. Wilson, E. Vaeth); Colorado Department of Public Health and Environment, Denver, Colorado, USA (W. Bamberg, S.J. Janelle); Minnesota Department of Health, St. Paul, Minnesota, USA (R. Lynfield, P.S. Vagnone, K. Shaw); Tennessee Department of Public Health, Nashville, Tennessee, USA (M. Kainer, D. Muleta, J. Mounsey); New York Rochester Emerging Infections Program at the University of Rochester Medical Center, Rochester, New York, USA (G. Dumyati, C. Concannon); Oregon Health Authority, Portland, Oregon, USA (Z. Beldavs, P.M. Cassidy); University of New Mexico, Albuquerque, New Mexico, USA (E.C. Phipps, N. Kenslow, E.B. Hancock)

Main Article

Table 2

Previous healthcare exposures among 598 carbapenem-nonsusceptible Acinetobacter baumannii cases‡ in Emerging Infections Program sites, United States, 2012–2015*

Healthcare exposure No. (%)
Healthcare facility exposure in the year before sample collection† 528 (88.3)
Previous acute care hospitalization 469 (78.4)
Residence in long-term care facility 360 (60.2)
Inpatient or outpatient surgery 199 (33.3)
Admission to long-term acute care hospital‡
 73 (14.0)
Current hemodialysis treatment
 66 (11.0)
Any indwelling device in place in 2 calendar days before sample collection 506 (84.6)
Urinary catheter 399 (66.7)
Central venous catheter 222 (37.1)
Other§
 269 (45.0)
No healthcare exposure 8 (1.3)

*The study areas were Denver, CO; Atlanta, GA; Baltimore, MD; Minneapolis/Saint Paul, MN; Albuquerque, NM; Rochester, NY; Portland, OR; Nashville, TN.
†Sum of subcategory percentages >100 due to patients with multiple healthcare exposures in year before case.
‡2013–2015 cases only; n = 521.
§Other indwelling devices: endotracheal or nasotracheal tube, tracheostomy, gastrostomy tube, nephrostomy tube, nasogastric tube.

Main Article

Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external